Medpace Holdings, Inc. (MEDP) financial statements (2020 and earlier)

Company profile

Business Address 5375 MEDPACE WAY
CINCINNATI, OH 45227
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments132232637
Cash and cash equivalents132232637
Restricted cash and investments 000
Receivables1561338380
Other undisclosed current assets29212016
Total current assets:317178130133
Noncurrent Assets
Operating lease, right-of-use asset52
Property, plant and equipment47524944
Intangible assets, net (including goodwill)717730760797
Goodwill662661661661
Intangible assets, net (excluding goodwill)546999136
Other noncurrent assets9765
Deferred tax assets, net160
Other undisclosed noncurrent assets0   
Total noncurrent assets:826790821846
TOTAL ASSETS:1,143968951979
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1321044035
Accounts payable22171711
Accrued liabilities109872424
Deferred revenue192
Debt   12
Deferred revenue and credits7466
Contract with customer, liability148
Other liabilities19553
Other undisclosed current liabilities  7452
Total current liabilities:343257193169
Noncurrent Liabilities
Long-term debt and lease obligation45104232180
Long-term debt, excluding current maturities 80205151
Capital lease obligations242729
Operating lease, liability45
Liabilities, other than long-term debt24132320
Deferred revenue and credits11 
Deferred tax liabilities, net0112
Liability for uncertainty in income taxes8   
Other liabilities1613118
Other undisclosed noncurrent liabilities54  
Total noncurrent liabilities:74121254200
Total liabilities:417378447368
Stockholders' equity
Stockholders' equity attributable to parent726590504611
Common stock0000
Treasury stock, value(6)(6)(6) 
Additional paid in capital667639630624
Accumulated other comprehensive loss(3)(3)(1)(4)
Retained earnings (accumulated deficit)68(41)(120)(10)
Total stockholders' equity:726590504611
TOTAL LIABILITIES AND EQUITY:1,143968951979

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues861705436422
Revenue, net436422
Cost of revenue(623)(498)(270)(257)
Cost of goods and services sold(615)(489)(50)(51)
Gross profit:238207166165
Operating expenses(110)(106)(101)(112)
Operating income:1271016552
Nonoperating expense(2)(7)(8)(31)
Other nonoperating income (expense)(1)1(0)(0)
Interest and debt expense   (11)
Income from continuing operations before equity method investments, income taxes:125945711
Other undisclosed income from continuing operations before income taxes   11
Income from continuing operations before income taxes:125945722
Income tax expense(24)(21)(18)(9)
Net income attributable to parent:100733913
Other undisclosed net loss available to common stockholders, basic(0)(0)(0)(0)
Net income available to common stockholders, diluted:100733913

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income:100733913
Comprehensive income:100733913
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(2)3(1)
Comprehensive income, net of tax, attributable to parent:100714212

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: